Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 HKEX Manufacturing
Open in API
Filings indexed 194 across all filing types
Latest filing 2025-12-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, share options, and treasury shares. It does not represent a specific corporate event like a dividend or M&A, but rather a recurring regulatory disclosure of share capital status. Therefore, it falls under the 'Regulatory Filings' category.
2025-12-03 English
UPDATE ON THE PROPOSED ISSUE OF SHARES UNDER GENERAL MANDATE AND SUPPLEMENTAL INFORMATION TO 2024 ANNUAL REPORT
Share Issue/Capital Change Classification · 1% confidence The document is an announcement from Broncus Holding Corporation regarding two distinct matters: an update on a proposed share issue (capital/financing activity) and supplemental information to their 2024 Annual Report. While it contains supplemental information, the primary purpose is to provide updates on capital structure and financing proceeds usage. Under the provided definitions, this fits best as a Capital/Financing Update (CAP) as it details the allocation of net proceeds from a share subscription and updates on the completion status of that financing.
2025-11-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, treasury shares, and share options. It does not represent a major corporate event like an earnings release or a dividend announcement, but rather a routine regulatory disclosure of share movements. Therefore, it falls under the 'Regulatory Filings' category.
2025-11-06 English
PROPOSED ISSUE OF SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement under the Hong Kong Listing Rules concerning the proposed allotment and issue of 105,108,015 new shares at HK$3.11 per share under the company’s existing general mandate. It details subscription agreements, share numbers, pricing, use of proceeds, conditions precedent, and changes in shareholding structure—all characteristic of a Share Issue/Capital Change announcement. Therefore it falls under Code SHA.
2025-10-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return filed with the Hong Kong Stock Exchange under Listing Rule Chapter 19B. It details movements in authorized share capital, issued shares, treasury shares, share options and confirms compliance with listing rules. This is not an earnings release, annual or interim report, director’s dealing, or proxy statement, but a regular regulatory submission. It thus falls under the general "Regulatory Filings" category (RNS).
2025-10-08 English
Reminder Letter and Reply Form to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a reminder letter to non-registered shareholders about the electronic dissemination arrangements for future corporate communications (annual report, interim report, notices, circulars, proxy forms, etc.). It is not the content of an annual or interim report, nor an earnings release, proxy solicitation or dividend notice. Instead, it is a general regulatory announcement regarding shareholder communications under listing rules. Therefore it falls into the fallback category of Regulatory Filings (RNS).
2025-09-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.